Javelin Pharmaceuticals shares plunged 30% Monday after Therabel Pharma N.V., Javelin's European commercial partner, was recalling all batches of its injectable pain drug Dyloject from the U.K. market due to quality control problems.
Javelin Pharmaceuticals rebounded Tuesday, climbing by 18 cents, or 14.3%, to $1.44. Volume topped 4.11 million shares, compared to the three-month average daily volume of 1.3 million, according to Yahoo! Finance.
Elsewhere, Navios Maritime Acquisition (NNA - Get Report) plummeted by $1.39, or 16.9%, to $6.83 after the company's shareholders approved the acquisition of 13 vessels plus options to purchase two additional product tankers, for $457.7 million, of which $334.3 million will come from debt financing.In addition, Navios Maritime Acquisition will reimburse Navios Maritime Holdings (NM - Get Report) $171.7 million for an initial payment made for the 11 vessels. Volume topped 518,000 shares, compared to the three-month average daily volume of 292,000. UQM Technologies (UQM - Get Report) also traded lower, falling by 42 cents, or 11.4%, to $3.25 after the electric motor company reported a fourth-quarter loss of 3 cents a share on revenue of $2.3 million, compared with the average analyst target for a profit of 3 cents a share on revenue of $2.4 million. Volume topped 460,000 shares, compared to the three-month average daily volume of 310,000. On the upside, Radcom (RDCM - Get Report) shares jumped by 64 cents, or 16.6%, to $4.50 in the absence of any company-specific news. Radcom announced on May 13 that it closed new deals for a total of approximately $1.5 million with two major Brazilian operators. Volume topped 95,000 shares, compared to the 50-day average daily volume of 85,000, according to the Nasdaq. -- Written by Robert Holmes in Boston. Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr. Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.